Early prostate cancer cases drop as PSA screening declines

When an influential federal panel recommended in 2012 that doctors omit prostate cancer screening from routine health care, it set off a firestorm.

Many men and their doctors seem to have heeded the advice, though the long-term implications won’t be clear for a while, a new analysis suggests.

The advice of the U.S. Preventive Services Task Force appears to have led to a sizable drop in screening with the PSA blood test, and in diagnosis of early-stage prostate cancer, according to American Cancer Society researchers who have been monitoring the trends.

Read Full Article Here >>